Skip to content

Syncope Prediction Study

Syncope Prediction Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02140567
Acronym
SPS
Enrollment
140
Registered
2014-05-16
Start date
2014-11-30
Completion date
2016-11-30
Last updated
2019-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vasovagal Syncope

Brief summary

The purpose of this study is to perform a prospective evaluation of the vasovagal syncope prediction algorithm, called Tilt Test Analyzer, during head up tilt testing tests in one center in the United Kingdom.

Detailed description

Vasovagal syncope (VVS) is a form of neurally-mediated reflex syncope, which is marked by a sudden fall in blood pressure with an associated fall in heart rate often resulting in syncope, head-up tilt (HUT) testing is commonly used to bring information about VVS using ECG and blood pressure monitoring with medical observation. We developed an algorithm, called Tilt Test Analyzer, to predict VVS during HUT based on the simultaneous analysis of heart rate (RR interval), systolic blood pressure (SBP) and an indicator of autonomic modulation represented by heart rate and blood pressure variability (HRV and BPV). The primary objective of this study is to evaluate the VVS prediction algorithm in a prospective cohort of patients in the tilt laboratory The primary endpoint is the VVS prediction algorithm performance by means of measuring the sensitivity and specificity values. The study is designed to test if the prospective analysis of tilt-test patients can reproduce the results previously obtained in the published retrospective analysis on 1155 patients with a similar clinically relevant sensitivity and specificity.

Interventions

None listed

Sponsors

Medtronic BRC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients referred to the center with vasovagal syncope for tilt testing. * The patient is willing and able to cooperate with the study procedures. * The subject or legal guardian is able to provide written informed consent

Exclusion criteria

* Patients under 18 years or over 90 years old. * Women who are currently pregnant or have a positive pregnancy test. * Patients who had a prior tilt test. * Patients enrolled in another device or drug study.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of the Syncope Prediction AlgorithmTilt Test with average duration of 1 hourNumber of tilt-positive participants predicted in the right way by the syncope prediction algorithm
Specificity of the Syncope Prediction AlgorithmTilt Test with average duration of 1 hourNumber of tilt-negative participants identified as negative by the syncope prediction algorithm

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Syncope Prediction
Enrolled participants who performed tilt test and were included in efficacy analysis
134
Total134

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProblems with recording equipment6

Baseline characteristics

CharacteristicSyncope Prediction
Age, Continuous37.2 years
STANDARD_DEVIATION 15.1
Sex: Female, Male
Female
92 Participants
Sex: Female, Male
Male
42 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 140
other
Total, other adverse events
0 / 140
serious
Total, serious adverse events
0 / 140

Outcome results

Primary

Sensitivity of the Syncope Prediction Algorithm

Number of tilt-positive participants predicted in the right way by the syncope prediction algorithm

Time frame: Tilt Test with average duration of 1 hour

Population: Number of participants with positive tilt-test

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Syncope Prediction (Sensitivity)Sensitivity of the Syncope Prediction AlgorithmTrue positive81 Participants
Syncope Prediction (Sensitivity)Sensitivity of the Syncope Prediction AlgorithmFalse negative2 Participants
Primary

Specificity of the Syncope Prediction Algorithm

Number of tilt-negative participants identified as negative by the syncope prediction algorithm

Time frame: Tilt Test with average duration of 1 hour

Population: Number of participants with negative tilt-test

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Syncope Prediction (Sensitivity)Specificity of the Syncope Prediction AlgorithmTrue negative45 Participants
Syncope Prediction (Sensitivity)Specificity of the Syncope Prediction AlgorithmFalse positive6 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026